AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 96 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $119,080 | +27.9% | 13,000 | 0.0% | 0.04% | +22.9% |
| Q4 2022 | $93,080 | +43.2% | 13,000 | 0.0% | 0.04% | +25.0% |
| Q3 2022 | $65,000 | +103.1% | 13,000 | 0.0% | 0.03% | +115.4% |
| Q2 2022 | $32,000 | -64.0% | 13,000 | 0.0% | 0.01% | -59.4% |
| Q1 2022 | $89,000 | -15.2% | 13,000 | 0.0% | 0.03% | -11.1% |
| Q4 2021 | $105,000 | -17.3% | 13,000 | 0.0% | 0.04% | -37.9% |
| Q3 2021 | $127,000 | +46.0% | 13,000 | 0.0% | 0.06% | +48.7% |
| Q2 2021 | $87,000 | – | 13,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,625,000 | $12,269,000 | 3.04% |
| GENDELL JEFFREY L | 1,146,764 | $8,658,000 | 1.11% |
| Broadfin Capital, LLC | 1,029,012 | $7,769,000 | 1.04% |
| RTW INVESTMENTS, LP | 3,401,434 | $25,681,000 | 0.97% |
| BRANDES INVESTMENT PARTNERS, LP | 3,651,948 | $27,571,000 | 0.66% |
| Aristides Capital LLC | 71,520 | $540,000 | 0.42% |
| Tekla Capital Management LLC | 814,588 | $6,150,000 | 0.23% |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 36,100 | $273,000 | 0.17% |
| Leap Investments LP | 43,481 | $328,000 | 0.15% |
| Brown Capital Management | 1,829,886 | $13,816,000 | 0.13% |